Sunday, December 5, 2021
Home Tags Sun Pharma

Tag: Sun Pharma

CDSCO Panel gives nod to Sun Pharma’s Dapagliflozin, Glimepiride, Metformin FDC

New Delhi: Pharmaceutical major, Sun Pharma, has got a go-ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization...

DCGI: Regulators & inventors should face no obstacles during developing new...

Dr. VG Somani, DCGI CDSCO At the Global Innovation Summit held by the Indian Pharmaceutical Alliance (IP Alliance),...

Sun Pharma to introduce Molnupiravir in India

Sun Pharma recently said that it is gearing up to introduce Merck Sharpe Dohme (MSD) and Ridgeback’s Molnupiravir under the brand name...

Pharma companies are awaiting DCGI nod to launch Covid-19 drug in...

MUMBAI: Sun Pharma said on Thursday it is gearing up to introduce antiviral Covid-19 drug, molnupiravir under the brand Molxvir at "an economical price'' in India....

Drug recall: Sun Pharma, Lupin recall products due to these reasons

Leading drug makers Sun Pharma and Lupin are recalling different products in the US, the world's largest market for medicines, for different reasons.

Sun Pharma launches acne treatment cream

New Delhi: Sun Pharmaceutical Industries announced the availability of Winlevi cream, used for the treatment of acne vulgaris in patients 12 years...

Sun Pharma launches drug to treat Plaque Psoriasis in Canada

Homegrown pharma major Sun Pharmaceutical Industries Ltd said it has launched its medicine ILUMYA. This drug is used in...

Sun Pharma launches a novel formulation for Cough management

Sun Pharmaceutical Industries on Tuesday said it has launched a novel formulation in cough management - Chericof 12 - in the country. The medication is...

Sun Pharma gets exclusive right for Winlevi acne cream in US,...

NEW DELHI: Sun Pharma and specialty pharma firm Cassiopea SpA announced consummation of their exclusive licence and supply agreements for Winlevi cream...

Sun Pharma, Cassiopea SpA ink agreements for Acne treatment drug

NEW DELHI: Drug major Sun Pharma on Monday said it has signed license and supply agreements with Cassiopea SpA for acne treatment drug...

Sun Pharma, Ferring Pharma sign agreement to launch CARITEC in India

Sun Pharmaceutical Industries announced that one of its wholly owned subsidiaries has entered into a license agreement with Ferring Pharmaceuticals, a subsidiary...

Sun Pharma acquires trademarks of 3 diabetes drug from AstraZeneca

Drug major Sun Pharma on Friday said it has acquired the rights to trademarks of diabetes drug Dapagliflozin under brands Oxra, Oxramet and Oxraduo in India from AstraZeneca Pharma India's parent...

Sun Pharma recalls 50,868 bottles of diabetes drug in US

Drug major Sun Pharma is recalling 50,868 bottles of diabetes drug Metformin HCl extended-release tablets in the US market, according to the US Food and Drug Administration (USFDA).

Lupin, Sun, Jubilant recall generic medicines in US

Lupin, Sun Pharma and Jubilant Cadista are recalling different products in the US, the world’s largest market for medicines, for different reasons.

Sun Pharma, Alembic recall products in the US market

Sun Pharma, Alembic recall products in the US market New Delhi: Leading drug makers Sun Pharma and Alembic Pharmaceuticals are recalling different products...

Govt to pharma firms: Ramp up Remdesivir Mfg to full capacity

The government said that all seven manufacturers of remdesivir in the country have been asked to ramp up production to full capacity...

These 4 Pharma companies invest in ABCD Technologies

Four pharma major companies have subscribed to partnership interest in ABCD Technologies LLP (to be renamed as IndoHealth Services LLP).

Pharma Companies recall these drugs in US

Sun Pharma, Dr Reddy’s Laboratories, Aurobindo Pharma and Jubilant Pharma are recalling products in the US market for various reasons.

Sun Pharma to launch entire range of Epilepsy treatment drug in...

Sun Pharmaceutical Industries announced that the company will introduce the complete range of Brivaracetam dosage forms at an affordable price for epilepsy...

DPCO-2013: Sun Pharma gets price exemption for this FDC

The National Pharmaceuticals Pricing Authority (NPPA) has granted exemption to Sun Pharmaceuticals from the provisions of DPCO, 2013 for its following FDC...

Sun Pharma recalls generic diabetes drug: USFDA

New Delhi: Leading drug maker Sun Pharma is recalling 747 bottles of generic diabetes drug in the US due to possibility of the affected lot containing...

Sun and Marksans Pharma voluntarily recall metformin

The USFDA is alerting patients and health care professionals to two voluntary recalls of extended release (ER) metformin by Marksans Pharma and...

Sun Pharma recalls metformin due to high NDMA levels

Sun Pharmaceutical Industries is voluntarily recalling one lot of RIOMET ER (metformin hydrochloride for extended-release oral suspension), 500 mg per 5 mL...

Sun Pharma launches ILUMYA – Tildrakizumab

Sun Pharmaceutical Industries announced that its wholly-owned Japanese subsidiary has launched ILUMYA subcutaneous injection 100 mg syringe (nonproprietary name: tildrakizumab) in Japan...

Latest posts

100 crore drug racket: Accused transported drugs in vehicle with Chandigarh...

Accused transported drugs in vehicle with Chandigarh number plate Zannet Pharmaceuticals’ owner Dinesh Bansal, arrested for illegal drug...

Authors

59 POSTS0 COMMENTS
30 POSTS0 COMMENTS
20 POSTS0 COMMENTS
15 POSTS0 COMMENTS
11 POSTS0 COMMENTS
9 POSTS0 COMMENTS
5 POSTS0 COMMENTS
5 POSTS0 COMMENTS
5 POSTS0 COMMENTS
4 POSTS0 COMMENTS
4 POSTS0 COMMENTS
3 POSTS0 COMMENTS
2 POSTS0 COMMENTS
2 POSTS0 COMMENTS
1 POSTS0 COMMENTS
1 POSTS0 COMMENTS
1 POSTS0 COMMENTS